# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Digital cancer care platform Careology and Evolent (NYSE:EVH) to offer an innovative platform to enable cancer navigationEvolen...
Second Quarter 2024 GuidanceFor the three months ended June 30, 2024, revenue is expected to be in the range of approximately $...
Evolent Health (NYSE:EVH) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.24 by ...
Citigroup analyst Daniel Grosslight initiates coverage on Evolent Health (NYSE:EVH) with a Buy rating and announces Price Ta...
Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $45 ...
JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $53 to ...
Oppenheimer analyst Jeff Jones initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price ...